THNR vs. EDEN ETF Comparison

Comparison of Amplify Weight Loss Drug & Treatment ETF (THNR) to iShares MSCI Denmark Capped ETF (EDEN)
THNR

Amplify Weight Loss Drug & Treatment ETF

THNR Description

The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$26.35

Average Daily Volume

2,962

Number of Holdings *

6

* may have additional holdings in another (foreign) market
EDEN

iShares MSCI Denmark Capped ETF

EDEN Description The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Denmark IMI 25/50 Index (the "underlying index"). The fund will at all times invest at least 90% of its assets in the securities of the underlying index or in depositary receipts representing securities in its underlying index. The underlying index is designed to measure broad-based equity market performance in Denmark. A capping methodology is applied that limits the weight of any single component to a maximum of 25% of the underlying index. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$122.02

Average Daily Volume

8,032

Number of Holdings *

2

* may have additional holdings in another (foreign) market
Performance
Period THNR EDEN
30 Days -4.50% -5.14%
60 Days 3.71% 0.87%
90 Days 0.30% -5.13%
12 Months 24.75%
1 Overlapping Holdings
Symbol Grade Weight in THNR Weight in EDEN Overlap
NVO F 12.82% 22.75% 12.82%
Compare ETFs